IBM shares retested a crucial multi-month resistance level as Bank of America analyst Wamsi Mohan reiterated his Buy rating and maintained a 12-month price target. The stock’s stabilizing momentum coincided with the unveiling of a new quantum computing research development aimed at accelerating IBM’s technology roadmap.
Bank of America analyst Wamsi Mohan retained his Buy rating on IBM and maintained his 12-month price target after assessing the stock’s recent trading action. Mohan highlighted that the current technical setup supports further upside potential if key levels hold.
IBM shares climbed to retest a multi-month resistance line near prior peaks, demonstrating stabilizing momentum following recent pullbacks. Technical indicators, including moving averages and volume trends, suggest buyers are re-entering positions at these levels.
IBM announced a new quantum computing research milestone on July 6, showcasing progress in error mitigation and scalable qubit architectures. The development reinforces the company’s leadership in quantum hardware and software integration for enterprise applications.
The combination of a maintained bullish analyst stance and tangible quantum research advances could provide fresh catalysts for IBM’s stock. Investors will monitor whether these developments translate into improved earnings growth and competitive positioning in hybrid cloud and quantum markets.
